A Study on the Patients Effected with Diabetic Retinopathy

Diabetes-related retinal disease (DR) is the subject of the investigation. One of the main reasons why diabetic individuals become blind is diabetic retinopathy syndrome. DR is classified into two major types, first Non-Proliferative Diabetic Retinopathy (NPDR) and the second Proliferative Diabetic Retinopathy (PDR). The treatment can be given to the patients based on the neovascularization (Abnormal Blood Vessel Growth) in the retina. Early findings of neovascularization are much important. Based on this report only an optometrist can identify, whether if the patient comes under NPDR or PDR. NPDR is further classified into three stages, Mild NPDR, Moderate NPDR and Severe NPDR. The main causes of vision impairment in this group of patients are of concern. Early diagnosis, careful observation, and appropriate evidence-based management—which frequently involves several different health care disciplines and professions—are necessary for diabetes and diabetic retinopathy (DR). The one area of the body where physical damage to blood vessels brought on by systemic disorders can be seen noninvasively is treated and observed by an optometrist. This highlights how crucial it is to keep an eye on all diabetic patients and collaborate with endocrinologists or primary care physicians (PCPs) to properly manage these individuals. In the past, skilled professionals would treat patients by hand. However, with the rapid advancement of technology, diabetic retinopathy may now be treated digitally. A specialist can identify the more intricate characteristics of the eye and treat patients appropriately.